BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 22976288)

  • 1. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls.
    Ando-Tanabe N; Iwamitsu Y; Kuranami M; Okazaki S; Yasuda H; Nakatani Y; Yamamoto K; Watanabe M; Miyaoka H
    Breast Cancer; 2014 Jul; 21(4):453-62. PubMed ID: 22976288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
    Debess J; Riis JØ; Engebjerg MC; Ewertz M
    Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
    Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
    Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
    Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
    Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function in breast cancer patients receiving adjuvant chemotherapy.
    Brezden CB; Phillips KA; Abdolell M; Bunston T; Tannock IF
    J Clin Oncol; 2000 Jul; 18(14):2695-701. PubMed ID: 10894868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive function in breast cancer patients on chemotherapy: a longitudinal study].
    Chen X; Li J; Zhu C; Li D; Zhang J; Wang K
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):27-30. PubMed ID: 24721302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.
    Chen X; Zhu C; Li J; Qiu L; Zhang L; Yu F; Ye R; Zhang J; Wang K
    Brain Res; 2013 Oct; 1533():63-72. PubMed ID: 23954744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide.
    Andryszak P; Wiłkość M; Żurawski B; Izdebski P
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28850754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
    Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
    Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
    Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P
    J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.